Learning Objectives
Upon completion of this activity, participants should be able to:
- Analyze new data on novel agents and therapeutic approaches for colorectal cancer
- Evaluate the role of molecular biomarkers in the treatment of patients with colorectal cancer
- Integrate new agents and treatment strategies into the clinical management of patients with colorectal cancer
- Employ novel treatment approaches to minimize oxaliplatin-associated peripheral neuropathy
CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.